Rylaze J Code: J9021
Injection, asparaginase, recombinant, (rylaze), 0.1 mg
Q4 2026 Medicare Payment Limit for J9021, effective October 1, 2026: $59.042 per HCPCS billing unit, up 0.6% from $58.698. From CMS's final file.
Drug & Product Overview
About Rylaze
Rylaze is a medication aligned to the HCPCS J Code: J9021 for billing, pricing, and reimbursement purposes in the United States. This Oncology medication is administered via the intramuscular route and manufactured by Jazz Pharmaceuticals.
According to CMS Drug Use Information: This product is used to treat certain types of cancers (acute lymphoblastic leukemia-ALL, lymphoblastic lymphoma-LBL). Asparaginase erwinia chrysanthemi works by starving tumor cells of needed nutrients and slowing tumor cell growth.
Disclaimer: This is a summary and does not contain all possible information about this product. For complete information about this product or your specific health needs, ask your healthcare professional.
NDC Code Information
Based on publicly available CMS files. Showing 1 of 2 NDCs — log in for the full crosswalk.
| NDC Code | Drug | Manufacturer | Billing Units / Pkg | Package Size |
|---|---|---|---|---|
| 68727-0900-03 | Rylaze | Jazz Pharmaceuticals, Inc. | 300 | 10 MG / 0.5 ML |
| •••••-••••-•• Log in to view | Rylaze | •••••••••••• Log in to view | •••• Log in to view | ••• •• / • •• Log in to view |
Rylaze Pricing & Reimbursement
National median reimbursement across major commercial payers.
Create an account on PayerPrice for more information →Historical Graphing and Billing Calculator
Log in to calculate billing and reimbursement with live ASP, WAC & AWP pricing.
Login to use the calculator →Rylaze CPT Administration Codes
The below list of CPT codes is intended for informational purposes only and may not be exhaustive. CPT® codes and descriptions are copyright American Medical Association (AMA). All rights reserved.
| CPT Code | Description |
|---|---|
| 96401 | Chemotherapy administration, subcutaneous or intramuscular; non-hormonal anti-neoplastic |
CMS has identified Rylaze (J9021) as a HCPCS code with single-dose containers. Therefore, the JW/JZ wastage modifiers could be required for billing purposes. Wastage billing guide →
Rylaze Medically Unlikely Edits (MUE)
The most billing units of J9021 Medicare will pay for one patient in one day, as published by CMS. 1 unit = 0.1 mg.
MAI 3 · Date of Service Edit: Clinical. Per-day limit based on clinical expectations; excess units are denied but may be appealed with documentation of medical necessity. See all MUE limits →
Rylaze Clinical Information
Indications and drug classification.
This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.
Login for BuyandBill.com Analytics
Unlock deeper insights with BuyandBill’s Comparative Report!
- Compare ASP, WAC, and AWP across drugs.
- Visualize Drug Price Movement Over Time
- Tailor reports to drug class, manufacturer, or HCPCS Code.
- Compare Biosimilar and 505(b)(2) products.
Frequently Asked Questions
Is there an available Rylaze billing and coding guide?
Are there any available Rylaze patient assistance programs?
Where can I find Rylaze prescribing information?
Where can I find Rylaze side effect information?
Does billing Rylaze require JZ/JW wastage modifiers?
About BuyandBill.com:
The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.
Related Drug Codes
Explore billing, coding, and pricing for drugs related to Rylaze.